Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Inglewood, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Murrieta, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Santa Maria, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Tustin, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Upland, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Victorville, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Victorville, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Ocala, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Sarasota, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Sebring, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Sebring, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Springfield, IL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Frederick, MD
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Lansing, MI
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
St. Clair Shores, MI
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
St. Clair Shores, MI
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Mayfield Village, OH
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Portland, OR
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Erie, PA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Erie, PA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Greer, SC
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Seattle, WA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
mi
from
Winnipeg,
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
mi
from
Winnipeg,
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Coon Joint Replacement Institue; St. Helena Hospital
mi
from
St. Helena, CA
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Coon Joint Replacement Institue; St. Helena Hospital
mi
from
St. Helena, CA
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Florida Orthopedic Institute
mi
from
Tampa, FL
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Florida Orthopedic Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Memorial Bone and Joint Research Foundation; Memorial Hermann Memorial City Medical Center
mi
from
Houston, TX
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Memorial Bone and Joint Research Foundation; Memorial Hermann Memorial City Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Yale University
mi
from
New Haven, CT
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
University of Rochester
mi
from
Rochester, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Emory University
mi
from
Atlanta, GA
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Clarksburg, WV
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Anniston, AL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Peoria, AZ
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Upland, CA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Ormond Beach, FL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Lexington, KY
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Flowood, MS
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Reno, NV
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Charleston, SC
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Chesapeake, VA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
mi
from
Sofia,
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
mi
from
Sofia,
Click here to add this to my saved trials